Inventor · disambiguated record
Jennifer Michaelson
Also filed as: MICHAELSON JENNIFER · MICHAELSON JENNIFER S
7 granted patents·11 pending applications·18 citations·filing 2007–2025
79Inventor score
Files withJOUNCE THERAPEUTICS INC7BIOGEN IDEC INC4CULLINAN THERAPEUTICS INC2BURKLY LINDA C1CULLINAN AMBER CORP1
Top patents by PatentIndex Score
18 records- 0187US10023635B2Antibodies to ICOSJOUNCE THERAPEUTICS INC·Filed 2016·Granted Jul 17, 2018·8 cites·47 claims
- 0282US10570203B2Antibodies to ICOSJOUNCE THERAPEUTICS INC·Filed 2018·Granted Feb 25, 2020·3 cites·24 claims
- 0380US10968277B2Gene signatures for determining ICOS expressionJOUNCE THERAPEUTICS INC·Filed 2016·Granted Apr 6, 2021·2 cites·21 claims
- 0478US8048635B2Measurement of soluble Tweak levels for evaluation of lupus patientsBIOGEN IDEC INC·Filed 2007·Granted Nov 1, 2011·5 cites·18 claims
- 0564US2021171635A1Antibodies to ICOSJOUNCE THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 0660US2022281978A1Compositions and Methods for the Treatment of Cancer (Anti-ICOS Antibody Dosing)JOUNCE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0757US2021340256A1Gene Signatures for Determining ICOS ExpressionJOUNCE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0856US2008279853A1Treatment of cancerBIOGEN IDEC INC·Filed 2007·Application pending·0 cites
- 0956US2025340651A1Anti-mica/b antibodies with enhanced effector function and methods of useCULLINAN MICA CORP·Filed 2023·Application pending·0 cites
- 1054US2024101630A1Bi-functional linear fusion collagen-localized immunomodulatory molecules and methods thereofCULLINAN AMBER CORP·Filed 2021·Application pending·0 cites
- 1151US2009324602A1Anti-fn14 antibodies and uses thereofBIOGEN IDEC INC·Filed 2009·Application pending·0 cites
- 1248US12404328B2Multi-specific binding proteins and methods of use thereofCULLINAN MAN INC·Filed 2019·Granted Sep 2, 2025·0 cites·26 claims
- 1348US9730947B2Method of treating lupus nephritisBURKLY LINDA C·Filed 2011·Granted Aug 15, 2017·0 cites·14 claims
- 1448US2025179181A1Multi-specific binding proteins and methods of use thereofCULLINAN THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1546US2023032087A1Anti-serum albumin antibodiesCULLINAN ONCOLOGY INC·Filed 2020·Application pending·0 cites
- 1645US2020024351A1Compositions and Methods for the Treatment of CancerJOUNCE THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 1742US2010272721A1Treatment of cancerBIOGEN IDEC INC·Filed 2010·Application pending·0 cites
- 1841US12428480B2Anti-CD19 antibodies and multi-specific binding proteinsCULLINAN THERAPEUTICS INC·Filed 2020·Granted Sep 30, 2025·0 cites·11 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →